Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements
-
Landseed Secures $400,000 Social-Impact Investment to Build the Measurement Layer for Nature-Based Markets
-
BiomX Announces NYSE American Acceptance of Plan to Regain Compliance
-
Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements
-
Capital Clean Energy Carriers Corp. Forms Joint Venture with CMA CGM S.A. to Build and Operate an LNG Bunkering Vessel
-
Leverage Shares by Themes Closing Capped Accelerated Single-Stock ETF Series Due to Lack of Assets
-
Every Moment Video Is Now Independently Verifiable on NBA Top Shot, Built by Dapper Labs on Flow Network
-
Dinari Brings SpaceX to Global Investors Through Regulated Financial Platforms and DeFi Markets
-
Aymer AI Announces Venture to Develop 90-Acre Powered Land Bank in Texas
-
Cuentas, Inc. Appoints Eric Kilinsky as Interim Chief Financial Officer and Names Ofek Haim Suchard Chief Artificial Intelligence Officer
-
AI Memecoin MemeToro Expands Ecosystem as Stage 1 Presale Gains Momentum
-
From Mini Series to Ultra Slim: LiTime Expands Its Compact Lithium Power Solutions for Space-Constrained Application
-
Teleport Named Most Innovative Identity and Access Management Platform in 2026 Cybersecurity Stars Awards
-
Defiance Gold Enhanced Options Income ETF (GLDY) Trading Halt
-
Real Canadian Superstore at Buffalo Run Set to Open This Fall
-
The Space Trade Is Just Beginning: 3 Small-Cap Names That Could Soar Alongside SpaceX
-
Shell announces pause in share buyback programme
-
ING reduces its stake in TMBThanachart Bank
-
NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares
-
Shell announces pause in share buyback programme
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Genesis Wins Best Fixed Income Trading Solution
-
Form 8.3 - Animalcare Group plc - Octopus Investments
-
Veyond Metaverse Closes Strategic Investment from Japan-Based Private Investor as Global Commercial Momentum Accelerates Across Its XR Medical Telepresence Platform
-
EXL and Databricks expand collaboration to help enterprises build trusted data foundations for AI
-
Shareholder Alert: Ademi LLP investigates whether Caesars Entertainment, Inc. is obtaining a Fair Price for Public Shareholders
-
BlockchAIn Announces Preliminary Inclusion in Russell Microcap® Index
-
Talisker Announces Amendment to Equity Incentive Plan and Adoption of Clawback Policy
-
APPlife Digital Solutions, Inc. Announces Reverse Stock Split
-
Shareholder Alert: Ademi LLP investigates whether AvalonBay Communities, Inc. is obtaining a Fair Price for Public Shareholders
-
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
-
NetworkNewsAudio Announces Audio Press Release (APR) Discussing Emerging AI Platform Companies in the Technology Ecosystem
-
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
-
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
-
BOXABL Unveils UFO Concept for Foldable Off-World Habitat Systems
-
Quantum Cyber Terminates At-the-Market Facility, Citing Strengthened Financial Position and No Immediate Capital Needs
-
Shareholder Alert: Ademi LLP investigates whether NCS Multistage Holdings, Inc. is obtaining a Fair Price for Public Shareholders
-
From Memecoin to Movement: Boobillions Raises Nearly $100,000 for The Keep A Breast Foundation
-
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Ann
-
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data
-
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its heal
-
OFA Group Receives Additional 180-Day Nasdaq Compliance Period; Nasdaq Confirms Company Remains Compliant with All Continued Listing Standards Other Than the Minimum Bid Price Requirement
-
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
-
MADD Canada to Honour Newfoundland and Labrador Police Officers for Outstanding Impaired Driving Enforcement
-
KE Holdings Inc. Announces Results of Annual General Meeting
-
American Cornerstone Institute to Premiere Star Spangled Adventures: The Movie! at the Trump Kennedy Center
-
Decisions of the Repeated Annual General Meeting of Shareholders of AB “Novaturas”
-
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
-
Everlert, Inc. (OTC: EVLI), Announces Discussions Regards Potential Acquisition of the Rimrock Copper-Gold Project in Nevada
-
Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients
